Show simple item record

Authordc.contributor.authorUchoa, E. T. 
Authordc.contributor.authorAguilera, G. es_CL
Authordc.contributor.authorHerman, J. P. es_CL
Authordc.contributor.authorFiedler Temer, Jenny es_CL
Authordc.contributor.authorDeak, T. es_CL
Authordc.contributor.authorDe Sousa, M. B. C. es_CL
Admission datedc.date.accessioned2014-12-15T14:46:43Z
Available datedc.date.available2014-12-15T14:46:43Z
Publication datedc.date.issued2014
Cita de ítemdc.identifier.citationJournal of Neuroendocrinology, 2014, 26, 557–572en_US
Identifierdc.identifier.otherdoi: 10.1111/jne.12157
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/121901
General notedc.descriptionArtículo de publicación ISIen_US
Abstractdc.description.abstractNormal hypothalamic-pituitary-adrenal (HPA) axis activity leading to the rhythmic and episodic release of adrenal glucocorticoids (GCs) is essential for body homeostasis and survival during stress. Acting through specific intracellular receptors in the brain and periphery, GCs regulate behaviour, as well as metabolic, cardiovascular, immune and neuroendocrine activities. By contrast to chronic elevated levels, circadian and acute stress-induced increases in GCs are necessary for hippocampal neuronal survival and memory acquisition and consolidation, as a result of the inhibition of apoptosis, the facilitation of glutamatergic neurotransmission and the formation of excitatory synapses, and the induction of immediate early genes and dendritic spine formation. In addition to metabolic actions leading to increased energy availability, GCs have profound effects on feeding behaviour, mainly via the modulation of orexigenic and anorixegenic neuropeptides. Evidence is also emerging that, in addition to the recognised immune suppressive actions of GCs by counteracting adrenergic pro-inflammatory actions, circadian elevations have priming effects in the immune system, potentiating acute defensive responses. In addition, negative-feedback by GCs involves multiple mechanisms leading to limited HPA axis activation and prevention of the deleterious effects of excessive GC production. Adequate GC secretion to meet body demands is tightly regulated by a complex neural circuitry controlling hypothalamic corticotrophin-releasing hormone (CRH) and vasopressin secretion, which are the main regulators of pituitary adrenocorticotrophic hormone (ACTH). Rapid feedback mechanisms, likely involving nongenomic actions of GCs, mediate the immediate inhibition of hypothalamic CRH and ACTH secretion, whereas intermediate and delayed mechanisms mediated by genomic actions involve the modulation of limbic circuitry and peripheral metabolic messengers. Consistent with their key adaptive roles, HPA axis components are evolutionarily conserved, being present in the earliest vertebrates. An understanding of these basic mechanisms may lead to novel approaches for the development of diagnostic and therapeutic tools for disorders related to stress and alterations of GC secretion.en_US
Patrocinadordc.description.sponsorshipThis study was supported by FAPESP and CNPq to E.T.U.; Intramural Research Program, National Institute of Child Health and Human Development to G.A.; NIH grants MH049698 and MH069860 to J.P.H.; FONDECYT 1120528 to J.L.F.; National Science Foundation (NSF) grant 0822129 to T.D.; and CNPq (Proc. No. 302592/2009-1) to M.B.C.S.en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherBritish Society for Neuroendocrinologyen_US
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectglucocorticoidsen_US
Títulodc.titleNovel Aspects of Glucocorticoid Actionsen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile